The Emirates Drug Institution has launched a nationwide programme aimed toward strengthening the inspection of pharmacovigilance practices throughout the pharmaceutical sector within the UAE.
The initiative was launched throughout a specialised workshop in Dubai, developed in cooperation with main business companions to enhance the protection of medicine and the standard of healthcare within the UAE.
The programme is designed to equip nationwide professionals with the talents wanted to judge pharmacovigilance techniques inside pharmaceutical firms. It additionally goals to ascertain a extra proactive regulatory framework constructed round early danger detection and detailed evaluation. The Institution mentioned it will help ongoing efforts to keep up excessive requirements of medicine security and affected person safety.
Sanofi companions in UAE drug security drive
The workshop, held in collaboration with world pharmaceutical firm Sanofi, is the primary joint session of its type between the Institution and the native pharmaceutical sector. It varieties a part of wider efforts to boost inspection readiness and introduce trendy regulatory instruments in keeping with worldwide requirements.
The 2-day programme targeted on sensible coaching overlaying the complete inspection cycle. This included pre-inspection planning, figuring out required documentation, making use of regulatory necessities, conducting discipline procedures and making ready stories and follow-up plans. Officers mentioned the workshop helps an institutional strategy that prioritises constructing specialised nationwide capabilities and strengthening regulatory preparedness.
The Institution mentioned the initiative displays a rising partnership with the pharmaceutical business aimed toward accelerating medicine security programmes and enhancing transparency in regulation and pharmacovigilance. It additionally helps the adoption of data-driven and evidence-based practices throughout the sector.
Dr Fatima Al Kaabi, Director Basic of the Emirates Drug Institution, mentioned: “The launch of the nationwide programme for inspecting pharmacovigilance practices will play a key position in supporting the Institution’s technique to construct an built-in regulatory system that prioritises affected person security and is constructed on efficient partnerships with the pharmaceutical sector.
“The Institution is dedicated to creating a number one pharmaceutical oversight system based mostly on proactive readiness and scientific proof and pushed by nationwide competencies able to main this qualitative transformation.”
She added that the Institution is exploring the enlargement of the programme to incorporate superior inspection schemes, up to date nationwide pharmacovigilance tips and the combination of inspection outcomes into digital and analytical techniques to help evidence-based determination making.
Preeti Futnani, MCO Lead and Basic Supervisor for Sanofi Specialty Care GCC, mentioned: “We’re proud to help the Emirates Drug Institution on this workshop carried out by means of official collaboration between regulatory authorities and the pharmaceutical sector.
“The UAE has established a transparent imaginative and prescient for regulatory improvement, and we’re dedicated to offering our world experience to contribute to this endeavour. Pharmacovigilance is a shared duty, and by constructing sturdy techniques collectively, we improve belief and elevate the standard of care.”
